Synthesis and in vitro evaluation of a selective antagonist and the corresponding radioligand for the prostaglandin D2 receptor CRTH2

https://doi.org/10.1016/j.bmcl.2007.07.080Get rights and content

Abstract

Synthesis and preliminary in vitro biological evaluation of a selective high-affinity CRTH2 antagonist is described. The stability of an N-benzyl group facilitated synthesis of the corresponding radioligand by tritiation of a brominated precursor. The compound [3H]TRQ11238 represents the first selective CRTH2 antagonist radioligand and exhibited a specific radioactivity of 52 Ci/mmol and a pKd of 9.0.

Graphical abstract

The first selective CRTH2 antagonist radioligand exhibits a pKd of 9.0 and a specific radioactivity of 52 Ci/mmol.

  1. Download : Download full-size image

Section snippets

Acknowledgment

This work was supported by the Danish Research Council.

References and notes (22)

  • E. Kostenis et al.

    Trends Mol. Med.

    (2006)
  • A.N. Hata et al.

    Pharmacol. Ther.

    (2004)
  • G. Monneret et al.

    Blood

    (2001)
  • T.N. Birkinshaw et al.

    Bioorg. Med. Chem. Lett.

    (2006)
  • D.A. Sandham et al.

    Bioorg. Med. Chem. Lett.

    (2007)
  • H. Sugimoto et al.

    Eur. J. Pharmacol.

    (2005)
  • H. Hammad et al.

    J. Exp. Med.

    (2007)
  • H. Hirai et al.

    J. Exp. Med.

    (2001)
  • J.L. Huang et al.

    Hum. Mol. Genet.

    (2004)
  • K. Takeshita et al.

    Int. Immunol.

    (2004)
  • I. Spik et al.

    J. Immunol.

    (2005)
  • Cited by (0)

    View full text